Zobrazeno 1 - 10
of 10
pro vyhledávání: '"Bernadette Alford"'
Autor:
Boris Zavizion, David J. Bzik, Bernadette Alford, John Wehrley Chapman, Andrei Purmal, Thomas N. Mather, Milena De Melo Jorge, Mercio Pereira, Diana Serebryanik, Nathan J. Miller
Publikováno v:
Transfusion. 44:731-738
BACKGROUND: The transmission of parasites, including Babesia, plasmodia, and Trypanosoma cruzi, via transfusions is an important public health concern. INACTINE technology is a pathogen-reduction process that utilizes PEN110, an electrophilic agent t
Publikováno v:
Transfusion. 44:476-484
BACKGROUND: The evaluation of pathogen reduction technologies with relevant viruses currently contaminating the blood supply is limited by the availability of high-titer virus inocula and sensitive in vitro or in vivo infectivity assays. Because HBV
Publikováno v:
Transfusion. 44:286-293
BACKGROUND: Mycoplasmas have been associated with multiple acute and chronic diseases. Mycoplasma genome is found in the blood of 10 to 15 percent of subjectively healthy individuals. If blood borne and viable in donated blood, mycoplasmas could pote
Autor:
Jodie Tassello, Robert B. Tesh, John Wehrley Chapman, Thomas N. Mather, Tsutomu Takeda, Diana Serebryanik, Asa Ohagen, Ed Kramer, Aris Lazo, Bernadette Alford, Fred Brown
Publikováno v:
Transfusion. 43:1029-1037
BACKGROUND The outbreak of West Nile virus (WNV) is the most recent reminder that the blood supply continues to be vulnerable to emerging and reemerging pathogens. A potentially prospective approach to reducing the risk of transfusion-transmitted inf
Autor:
Gary S. Kopf, Philip Kraker, Roberta Hines, Louis A. Matis, Richard K. Shaw, Gregory L. Stahl, Bernadette Alford, Sary F. Aranki, Lan Li, Ruth O'Hara, Charles D. Collard, Michael L. Dewar, Henry M. Rinder, Scott A. Rollins, Brian G. Smith, Jane C. K. Fitch, John A. Elefteriades, Stanton K. Shernan, Christine S. Rinder
Publikováno v:
Circulation. 100:2499-2506
Background —Cardiopulmonary bypass (CPB) induces a systemic inflammatory response that causes substantial clinical morbidity. Activation of complement during CPB contributes significantly to this inflammatory process. We examined the capability of
Autor:
Boris, Zavizion, Mercio, Pereira, Milena, de Melo Jorge, Diana, Serebryanik, Thomas N, Mather, John, Chapman, Nathan J, Miller, Bernadette, Alford, David J, Bzik, Andrei, Purmal
Publikováno v:
Transfusion. 44(5)
The transmission of parasites, including Babesia, plasmodia, and Trypanosoma cruzi, via transfusions is an important public health concern. INACTINE technology is a pathogen-reduction process that utilizes PEN110, an electrophilic agent that inac-tiv
Autor:
Shahika, Aytay, Asa, Ohagen, Michael R, Busch, Bernadette, Alford, John R, Chapman, Aris, Lazo
Publikováno v:
Transfusion. 44(4)
The evaluation of pathogen reduction technologies with relevant viruses currently contaminating the blood supply is limited by the availability of high-titer virus inocula and sensitive in vitro or in vivo infectivity assays. Because HBV infectivity
Publikováno v:
Transfusion. 44(2)
Mycoplasmas have been associated with multiple acute and chronic diseases. Mycoplasma genome is found in the blood of 10 to 15 percent of subjectively healthy individuals. If blood borne and viable in donated blood, mycoplasmas could potentially be t
Autor:
Thomas, Mather, Tsutomu, Takeda, Jodie, Tassello, Asa, Ohagen, Diana, Serebryanik, Ed, Kramer, Fred, Brown, Robert, Tesh, Bernadette, Alford, John, Chapman, Aris, Lazo
Publikováno v:
Transfusion. 43(8)
The outbreak of West Nile virus (WNV) is the most recent reminder that the blood supply continues to be vulnerable to emerging and reemerging pathogens. A potentially prospective approach to reducing the risk of transfusion-transmitted infections of
Publikováno v:
Anesthesiology. 87:63A